Richard Scolyer
Richard Scolyer | |
|---|---|
| Born | Richard Anthony Scolyer 16 December 1966 Launceston, Tasmania |
| Education | University of Tasmania University of Sydney |
| Occupation(s) | Pathologist, Co-Medical Director and Translational Researcher |
| Organization | Melanoma Institute Australia |
| Spouse | Katie Nicoll[1] |
| Children | 3[2] |
Richard Anthony Scolyer (born 16 December 1966[3]) is an Australian pathologist. He is a senior staff specialist in tissue pathology and diagnostic oncology at Royal Prince Alfred Hospital,[4][5] co-medical director at the Melanoma Institute Australia,[6] and Conjoint professor at the University of Sydney.[7]
Career
[edit]Scolyer provides a clinical consultation service for the diagnosis of difficult pigmented lesions and receives more than 2000 cases for opinion from Australasia and beyond annually. He integrates his clinical practice with co-leading a translational melanoma research laboratory.[6]
In February 2019, he was ranked the world's 10th leading publisher on the topic of melanoma and the world's leading publisher in melanoma pathology.[8] Scolyer has co-authored more than 700 publications and book-chapters on the subject,[4][6] and was an editor of the 4th Edition of the WHO Classification of Tumours.[9]
Cancer diagnosis and treatment
[edit]![[icon]](/wiki/File:Wiki_letter_w_cropped.svg){kind=small} | This section needs expansion. You can help by adding to it. (January 2024) |
Scolyer was diagnosed with an incurable brain cancer, glioblastoma IDH wild-type, in June 2023.[1] He underwent combination immunotherapy before surgical excision, a sequence Scolyer and his colleagues have applied successfully for melanoma, but is non-standard for brain cancer due to concerns about toxicity, whether drugs will reach the brain, and speed of tumour development. As of twelve months after surgery, Scolyer's cancer has not returned, a promising result with potentially broader implications, though oncologists warn that it is too early to judge effectiveness versus standard protocols.[10]
Awards and recognition
[edit]Scolyer received the New South Wales Premier's Award for Outstanding Cancer Research in 2009, 2012, 2013, 2014, 2016, 2017, 2018 and 2020.[11]
He was appointed an Officer of the Order of Australia for "distinguished service to medicine, particularly in the field of melanoma and skin cancer, and to national and international professional organisations" in the 2021 Queen's Birthday Honours.[4]
He was named 2024 Australian of the Year alongside Georgina Long by the National Australia Day Council, a not-for-profit Australian Government-owned social enterprise.[12]
References
[edit]- ^ a b MacLennan, Leah (20 September 2023). "Cancer expert given experimental treatments for incurable brain tumour describes 'phenomenal' results". ABC News. Retrieved 20 September 2023.
- ^ Burns, Brielle (4 December 2023). "Doctor facing 'certain death' does unthinkable". news.com.au. Retrieved 2 January 2024.
- ^ https://australianoftheyear.org.au/sites/default/files/2024-01/media_release_-_2024_australian_of_the_year_awards_announcement.pdf
- ^ a b c "Professor Richard Anthony Scolyer". It's an Honour. Retrieved 13 June 2021.
- ^ "Tissue Pathology at RPA". www.tissuepathologyatrpa.com.au. Retrieved 6 February 2021.
- ^ a b c "Our team". Melanoma Institute Australia. Retrieved 13 August 2020.
- ^ "Staff Profile". The University of Sydney. Retrieved 13 August 2020.
- ^ "Melanoma: Worldwide - Expertscape.com". expertscape.com. Retrieved 13 August 2020.
- ^ DE, Elder; D, Massi; RA, Scolyer; R, Willemze (11 September 2018). WHO Classification of Skin Tumours. World Health Organization. ISBN 978-92-832-2440-2.
- ^ Turnbull, Tiffany. "Richard Scolyer: Melanoma doctor's high-stakes gamble to treat his brain cancer". BBC News. BBC. Retrieved 3 February 2024.
- ^ "NSW Premier's Awards for Outstanding Cancer Research".
- ^ "Who are Georgina Long and Richard Scolyer, the 2024 Australians of the Year?". SBS News. 25 January 2024. Retrieved 25 January 2024.
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
